New combo therapy targets abdominal cancer spread in early trial

NCT ID NCT07453875

Not yet recruiting Disease control Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new treatment plan for people with stomach or colorectal cancer that has spread to the lining of the abdomen. The approach combines low-dose radiation to the whole abdomen with chemotherapy and an immunotherapy drug. The main goal is to check if the treatment is safe and tolerable. About 9 to 18 participants will take part at one hospital in China.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LDRT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal neoplasm peritoneal carcinomatosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LDRT PERITONEAL METASTASIS OF GASTRIC AND COLORECTAL CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Army Medical Center

Chongqing, Chongqing Municipality, 400042, China
Daping Hospital, Army Medical University

Chongqing, Chongqing Municipality, 400042, China

Contact Phone: •••-•••-•••• Email: •••••@•••••